tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Catanzaro, 225 are a BUY (76.79%), 68 are a HOLD (23.21%).
Analyst Joseph Catanzaro, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 38.92% that have a potential upside of 43.12% achieved within 133 days.
Joseph Catanzaro’s has documented 568 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on CRDF, Cardiff Oncology at 13-Dec-2024.
Analyst best performing recommendations are on CLVS (CLOVIS ONCOLOGY).
The best stock recommendation documented was for CPRX (CATALYST PHARMACEUTICALS) at 11/10/2021. The price target of $7 was fulfilled within 1 day with a profit of $0.55 (8.53%) receiving and performance score of 85.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$1.75
$-1.41 (-44.62%)
$5
4 months 3 days ago
(27-Aug-2024)
1/6 (16.67%)
$0.07 (4.17%)
2
Hold
4 months 9 days ago
(21-Aug-2024)
0/4 (0%)
$31.56 (191.97%)
Buy
$1.5
$-1.66 (-52.53%)
4 months 9 days ago
(21-Aug-2024)
0/2 (0%)
$-0.05 (-3.23%)
Buy
2 years 8 months 19 days ago
(11-Apr-2022)
0/1 (0%)
$93 (163.16%)
Buy
2 years 8 months 19 days ago
(11-Apr-2022)
2/2 (100%)
$4.5 (25.00%)
82
Which stock is Joseph Catanzaro is most bullish on?
Which stock is Joseph Catanzaro is most reserved on?
What Year was the first public recommendation made by Joseph Catanzaro?
